Impact of Published Data on Pediatric Status Epilepticus Treatment Delay
Published evidence of delays in treatment for pediatric rSE was not associated with improvement in time to treatment but with an increase in those who received BZD.
Pediatrics
Higher Relapse Risk For Depression Between Childhood and Adolescence
Children who receive a depression diagnosis in their primary school age have a substantially higher risk of a depression relapse during adolescence compared with children who did not receive a depression diagnosis during their primary school age.
Prenatal Cannabis Exposure Tied to Childhood Sleep Problems
Prenatal cannabis use was associated with disorders of arousal, sleep wake disorders, disorders of excessive somnolence, and a summed sleep disorder score.
ENIGMA Study Finds Age Related Cortical Differences in ADHD, ASD, and OCD
Despite being common and often comorbid neurodevelopmental disorders, the study found robust yet subtle differences across age groups and the disorders in terms of cortical and subcortical brain structures.
APA, AACAP Release Recommendations for School Reopening
The APA and AACAP offered 8 recommendations for school reopening plans due to the importance of precautions during the coming school year.
Incidence of Abusive Head Trauma in Infants May Be Up During Lockdown
From March 23 to April 23, 2020, there was a very large increase in the incidence of abusive head trauma seen in very young children.
Depression More Common in Children With vs Without Chronic Migraine
Compared with healthy control participants, pediatric patients with chronic migraine reported a higher rate of depression.
Brain Structure and Function Become Coupled During Cognitive Maturation in Adolescents
A neuroimaging study has identified network-level plasticity mechanisms involved in cognitive maturation during adolescence and into adulthood.
Gene Therapy for Mucopolysaccharidosis Type IIIA Gets Fast Track Designation
The Food and Drug Administration (FDA) has granted Fast Track designation to LYS-SAF302 (Lysogene), an investigational gene therapy for the treatment of mucopolysaccharidosis Type IIIA (MPS IIIA).
Test for Fragile X Syndrome Screening, Diagnosis Gets FDA Clearance
A diagnostic test for fragile X syndrome (FXS) has been cleared by the Food and Drug Administration.
-
Loading...
-
Loading...
Next post in Pediatric Neurology
